A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis
A Prospective, Multi-Center, Parallel, Randomized, Double-Blinded Study of the Efficacy and Safety of the Ulthera® System for the Treatment of Primary Axillary Hyperhidrosis
Sponsor: Ulthera, Inc
Terminated
Sponsor decision; unexpectedly high sham response at primary outcome time point.
Other terminated trials from Ulthera, Inc
- Skin Laxity · Phase NA · Apr 2017
- Skin Laxity · Phase NA · Aug 2016
- Peri-oral Wrinkles · Phase NA · Aug 2014
- Surgical Scar · Phase NA · Feb 2014
- Skin Laxity · Phase NA · Oct 2013
More terminations from Ulthera, Inc
Listed as NCT01722461, this NA trial focuses on Primary Axillary Hyperhidrosis and remains terminated or withdrawn. Sponsored by Ulthera, Inc, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Terminated NA
-
Dec 2017 — Feb 2018 [monthly]
Terminated NA
-
Feb 2017 — Dec 2017 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Nov 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ulthera, Inc
For direct contact, visit the study record on ClinicalTrials.gov .